COVID-19 相关细胞系，旨在研究SARS-CoV-2和开发治疗方法
它们被专门设计用来研究SARS-CoV-2感染以及开发新的针对病毒或随后的促炎症免疫反应治疗方法。
细胞系 | 产品名称 | 概述 | 报告系统 | 货号 |
COVID-19-RELATEDCELLLINES | ||||
HEK293 (human) | HEK-Blue™hACE2 | HumanACE2-expressingreporterCells | SEAP | hkb-hace2 |
HEK-Blue™hACE2-TMPRSS2 | HumanACE2-TMPRSS2expressingreporterCells | SEAP | hkb-hace2tpsa | |
293-SARS2-S-dfur | SARS-CoV-2spike(D614) withaninactivefurin(dfur)cleavagesite | None | 293-cov2-sdf | |
293-SARS2-S | SARS-CoV-2spike(D614)-expressingHEK293cells | None | 293-cov2-s | |
293-hMyD88 | HEK293-derived'donor'celllineforcellfusion | None | 293-hmyd | |
A549 (human) | A549-hACE2 | HumanACE2ExpressingCells | None | a549-hace2 |
A549-hACE2-TMPRSS2 | HumanACE2andTMPRSS2ExpressingCells | None | a549-hace2tpsa | |
A549-Dual™hACE2-TMPRSS2 | HumanACE2&TMPRSS2Expressing(NF-κB-SEAP&IRF-Lucia) | SEAP/Lucia | a549d-cov2r | |
A549-Dual™KO-MDA5hACE2-TMPRSS2 | HumanMDA5Knockout—ACE2&TMPRSS2Expressing | SEAP/Lucia | a549d-komda5-cov2r | |
A549-Dual™KO-RIG-IhACE2-TMPRSS2 | HumanRIG-IKnockout—ACE2&TMPRSS2Expressing | SEAP/Lucia | a549d-korigi-cov2r | |
A549-ASC-GFP-NLRP1 | HumanACE2,TMPRSS2&NLRP1lungreportercells | GFP | a549-ascov2-nlrp1 | |
A549-ASCOV2 | HumanACE2&TMPRSS2lungreportercells | GFP | a549-ascov2 | |
InvivoGen提供了一套不断扩展的SARS-CoV-2刺突蛋白质粒系列，用于细胞表达或构建刺突蛋白假病毒 :
名称 | 变种 | |
Original | Wuhan-Hu-1 (Clade 19) |
|
G614 variant | Clade 20 | |
Alpha | B.1.1.7 variant | United Kingdom (Clade 20I) | |
Beta | B.1.351 variant | South Africa (Clade 20H) | |
Epsilon | B.1.429 variant | California (Clade 21C) | |
Gamma | P.1 variant | Brazil (Clade 20J) | |
Iota | B.1.526 variant | New York(Clade 21F) | |
Kappa | B.1.617.1 variant | India (Clade 21B) | |
Delta| B.1.617.2 variant | India (Clade 21B) | |
Lambda | C.37 variant | Peru (Clade GR/452Q.V1) | |
Mu | B.1.621 variant | Colombia (Clade 21H) | |
Omicron | B.1.1.529/BA.1 variant | South Africa (Clade 21K) | |
Omicron | BA.2 variant | South Africa (Clade 21L) | |
Omicron | BA.4/BA.5 variant | South Africa (Clades 22A & 22B) |
详情请联系 Invivogen 全国授权代理-欣博盛生物科技
全国服务热线: 4006-800-892 邮箱: market@neobioscience.com
深圳: 0755-26755892 北京: 010-88594029
广州：020-87615159 上海: 021-34613729
代理品牌网站: www.neobioscience.com
自主品牌网站: www.neobioscience.net
